Prognostic modeling for diffuse midline glioma: development and validation of a risk stratification nomogram using SEER and institutional cohorts
{{output}}
Background: Diffuse midline glioma (DMG) is a rare and highly aggressive central nervous system tumor with limited treatment options and poor survival outcomes. Reliable prognostic models are urgently needed to guide risk-adapted... ...
